Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort ...
Le Lézard

Dr. Kevin Rhodes Joins NCMA Nexus 2026 to Share Insights on Transforming Federal Procurement

The National Contract Management Association (NCMA) is pleased to announce that Dr. Kevin Rhodes, Administrator of the Office of Federal Procurement Policy (OFPP), will join NCMA Nexus 2026 as a ...
Le Lézard

Valinor Raises $13 Million to Increase Clinical Trial Success Rates with Proprietary ML Models

Valinor, a pioneering AI company leveraging advanced machine learning models to increase the probability of clinical trial success by deeply understanding patient response, today announced $13 million ...